4
Changes in Ownership
Lipocine Inc. Filed Acc 0001638599-18-000026
Director sold 875 shares at $3.47 ($3,033)
- Director acquired 1,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ono Richard Dana Director | 2017-12-29 | Option exercise | +1,750 | 5,750 | D: show line 1 in the form | ||
| Ono Richard Dana Director | 2017-12-29 | Sale | −875 | $3.47 | $3,033 | 4,875 | D: show line 2 in the form |
| Open-market sales · 875 sh · avg $3.47 · $3,033 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Ono Richard Dana Director | 2017-12-29 | Option exercise · Restricted Stock Unit | −1,750 | 5,250 | D: show line 3 in the form |
Loading xslF345X03/doc4_5174.xml…